Home / Chemicals / Hyaluronic

Hyaluronic Acid Market By Product Analysis (Product Type, Single Injection, Three Injection, Five Injection), Application Analysis (Application Type, Dermal Fillers, Adhesive Prevention, Osteoarthritis) - Growth, Share, Opportunities & Competitive Analysis, 2015 - 2022

The study covers the basic overview of the hyaluronic acid market such as introduction, classification, and supply chain among others. In addition, to understand the competitiveness of the market porter’s five force analysis is also included.

The study provides a decisive view of the hyaluronic acid market by segmenting it based on regional demand, product type and applications. Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, and RoW. These have been further sub-segmented into countries relevance to the market. By product types it includes single injection, three Injection and five injection. Based on applications the market is segmented by vesicoureteral reflux, dermal fillers, adhesive prevention and osteoarthritis.

This study also covers the factors driving and restraining the market dynamics with their impact during the forecast period. To provide a comprehensive view of the market the study includes profiling of key player such as Allergan Inc., Seikagaku, Ferring Pharmaceuticals, Sanofi Inc., Anika Therapeutics Inc., AstraZeneca, and Ferring Pharmaceuticals among others.

Purpose of the Report

The purpose of this strategic research study titled “Global Hyaluronic Acid Market” is to provide company executives, industry investors, and industry participants with in-depth insights to enable them make informed strategic decisions regarding the opportunities in the global hyaluronic acid market.

Target Audience

  • Industry investors
  • Raw material suppliers
  • Distributors
  • Manufacturers
  • Retailers
  • Companies who want to enter the market and companies who want to diversify their product portfolio

USP and Key Offerings

This report analyses the worldwide markets for hyaluronic acid in USD billion by the following application type’s such as vesicoureteral reflux, dermal fillers, adhesive prevention and osteoarthritis. The study also includes analysis based on product type such as single, three and five injections. The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific and Rest of World (RoW). Annual estimates and forecasts are provided for the period 2014 through 2022 and market growth rate is calculated from 2015 to 2022. Market data and analytics are derived from primary and secondary research. We have considered demand side approach of the market. Competitive analysis is primarily based on public domain information including company URLs and company annual report.

Other in-depth analyses provided in the report include:

  • Current and future market trends to justify the forthcoming attractive markets within hyaluronic acid market
  • Market drivers, market restraints, and their impact on the market growth
  • In-depth competitive analysis of players present in the market
  • SRC (Segment-Region-Country) Analysis

Overall, the research study provides a holistic view of the global hyaluronic acid market, of growth offering market size and estimates for the period from 2015 to 2022, keeping in mind the above mentioned factors.

The application segments covered in the study include vesicoureteral reflux, dermal fillers, adhesive prevention and osteoarthritis. Dermal fillers is the largest application segment for hyaluronic acid. It accounted for 37% share of the market in 2014 in terms of revenue. In 2014, the consumption of hyaluronic acid in dermal filler was USD 1.16 billion.

Hyaluronic Acid Market 

Vesicoureteral reflux segment is projected to be the highest growth segment of the market.

On the basis of geography, the global hyaluronic acid market is segmented into following regions,

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Rest of the World
    • Brazil
    • Rest of RoW 

North America is the largest market and accounted for 38% share of the market in 2014. The market is primarily enhanced by growing geriatric population and their treatment needs. North America is projected to maintain its dominance during the forecast period. 

 Hyaluronic Acid Market

Asia Pacific is projected to be the fastest growing market at a CAGR of 10.1% from 2015 to 2022. Growing awareness among the population and enhancement in health care infrastructure is the major factor attributing towards the market growth. RoW is another lucrative market for hyaluronic acid.


Choose License Type
Published Date:  Apr 2016
Category:  Chemicals
Report ID:   57809
Report Format:   PDF
Pages:   120
Rating:    4.3 (60)
Connect With Us
24/7 Research Support